Menu
Home
Uitgevers
Categorieën
Trending
Inbox
Account aanmaken
Aanmelden
English
Deutsch
Niaid.nih.gov
10250
Nieuwsbrieven
0
Abonnementen
Abonneren
Klik hier om u te abonneren op Niaid.nih.gov
Nieuwsbrieven
Understanding COVID-19 | Vitiligo | COVID-19 Prote ction | Kidney Disease | COVID-19 Spanish Resources
Niaid.nih.gov
3 jaren geleden
NIH to evaluate COVID-19 at-home testing system
Niaid.nih.gov
3 jaren geleden
Statement from NIH and BARDA on the FDA Emergency Use Autho rization of the Janssen COVID-19 Vaccine, February 27, 2021
Niaid.nih.gov
3 jaren geleden
Whats New in the COVID-19 and HIV Interim Guidance
Niaid.nih.gov
3 jaren geleden
Study identifies cardiovascular risk factors that may lead to pregnancy problems for first-time moms
Niaid.nih.gov
3 jaren geleden
Chocolate | Kid's Dental Health | Diet | Clinical Trials | Hospice
Niaid.nih.gov
3 jaren geleden
New Director's Message: Shining a Light on COVID-19s Long Shadow
Niaid.nih.gov
3 jaren geleden
Considering SHOP Coverage for Your Employees?
Niaid.nih.gov
3 jaren geleden
Using R2D2 to Understand RNA Folding
Niaid.nih.gov
3 jaren geleden
Whats New in the Guidelines fo r the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
Niaid.nih.gov
3 jaren geleden
New Clinical Digest: Menopausal Sympto ms and Complementary Health Approaches
Niaid.nih.gov
3 jaren geleden
NIH study finds that people with SARS-CoV-2 ant ibodies may have a low risk of future infection
Niaid.nih.gov
3 jaren geleden
New experiences enhance learnin g by resetting key brain circuit
Niaid.nih.gov
3 jaren geleden
The Impact of Music on Health - Sound Health Netw ork Launched to Raise Awareness, Promote Research
Niaid.nih.gov
3 jaren geleden
Application Deadline Extended for Nurse Corps Loan Repayment Program
Niaid.nih.gov
3 jaren geleden
Public Health England NOIDS Update
Niaid.nih.gov
3 jaren geleden
Monoclonal antibodies against MERS coronaviru s show promise in Phase 1 NIH-sponsored trial
Niaid.nih.gov
3 jaren geleden
Screening for suicide risk | Masks and COVID-19 | Engineered cartilage
Niaid.nih.gov
3 jaren geleden
Mouse study shows bacteriophage therapy coul d fight drug-resistant Klebsiella pneumoniae
Niaid.nih.gov
3 jaren geleden
Is One Vaccine Dose Enough After COVID-19 Infection?
Niaid.nih.gov
3 jaren geleden
Begin
Vorige
183
184
185
186
187
188
189
190
191
192
Next
© 2024
Algemene voorwaarden
Privacy
Sluit
Home
Uitgevers
Categorieën
Trending
Inbox
Account aanmaken
Aanmelden
© 2024
Algemene voorwaarden
Privacy
English
Deutsch